exhibition icon
register now icon
get brochure icon
sponsors icon
add event to diary icon
email this to... icon
contact us icon
Breakthrough
our speakers
Zhaosheng Lin
Head of Biomarkers
Pfizer
 
Nadine Cohen
Head of Pharmacogenomics
Johnson & Johnson
 
Mitchell B. Friedman
Director of Toxicology
Takeda Global R&D
 
Malcolm Mitchell
Medical Director, Clinical Pharmacology
Eli Lilly
 
Dr Russell Weiner
Group Director
Bristol-Myers Squibb
conference details
Conference:
Pre-conference workshop
19 Oct 9am - 5pm
Day 1
20 Oct 8.30am - 5:30pm
Day 2
21 Oct 8.30am - 5:30pm
Post-conference workshop
22 Oct 9am - 5pm
 
Venue: Boston, MA, United States

› Email a friend
› Add this to my calendar

Register online now 
or call +44 (0) 207 608 7055
Contact LIVE
Location
Exploratory Clinical Development World Americas 2010

Breakthrough

When: 20 Oct - 21 Oct
Where: Le Meridien Hotel, Cambridge Massachusetts
Category: Conference

Dr Mitchell Friedman, speaking at Exploratory Clinical Development World Americas 2010

Dr Mitchell Friedman,
Director of Toxicology
Takeda Global R&D

Appearing:
Day Two, Thursday 21 October 2010
12pm

PANEL SESSION: Strategies to Identify and Mitigate Risk in Early Clinical Trials

Dr Mitchell Friedman,
Director of Toxicology,
Takeda Global R&D
Malcolm Mitchell,
Medicial Director, Clinical Pharmacology,
Eli Lilly and Company
Dr Andrea Pellacani,
Senior Director, Clinical Researc, Therapeutic Area Lea, Early Development Biologics,
Merck Ltd
Register Now! »
event sponsors

 

Follow us on Twitter
Twitter logo

› follow us! › tweet this!

Reserve a stand
Reserve an exhibition stand at the Exploratory Clinical Development World Americas exhibition - book early to ensure optimum stand placement!

 
Reserve a stand
 
For details contact
Claire Conway on +44 (0) 207 608 7058

 > Exhibitor FAQ's

comment / report a mistake | contact us | about Terrapinn | site map | privacy | T&Cs a terrapin ©Terrapinn Holdings Ltd. MMX